The significantly decreased expression of genes encoding insulin, IGF-I, and IGF-II, as well as the insulin and IGF-I receptors in the CNS suggested that AD may be a type 3 diabetes in the brain, yet it is different from diabetes mellitus 26. This evidence concerns the gene IGF2 and diabetes mellitus.